GSK’s Pakistan unit is scaling back production of the painkiller Panadol amid a growing health emergency triggered by recent flooding in the country. In a filing (PDF) with the Pakistan Stock Exchange ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

GSK plc, aka GlaxoSmithKline, is rated a Buy at or below $45 due to relative undervaluation and a balanced, diversified portfolio. GSK's recent CEO transition and solid Q2 earnings have improved ...

GlaxoSmithkline is a world leader in producing premium health-care products and medicines. Our well-known brands are household names, which cannot be permitted to be compromised through counterfeiting ...